DN
DNA Group (T.R.) Ltd.
DNA | TA
Overview
Corporate Details
- ISIN(s):
- IL0011038523
- LEI:
- Country:
- Israel
- Address:
- Shimon Hatars' 43, 6249245 Tel Aviv
- Website:
- http://www.dnas.co.il
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
DNA Group develops and markets technological solutions for defense and homeland security sectors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-10 18:41 |
M&A Activity
Following the completion of a Big Allotment and in light of the company's compl…
|
English | 156.3 KB | ||
| 2025-11-10 17:02 |
Regulatory News Service
Zero Weight Cap Factor in TASE Indices
|
English | 116.1 KB | ||
| 2025-11-10 16:10 |
Delisting Announcement
Base price of 1 agora and unlimited price fluctuation
|
English | 91.6 KB | ||
| 2022-11-06 14:35 |
Regulatory News Service
Changes in the company's names and security names , effective as of f November …
|
Hebrew (modern) | 149.0 KB | ||
| 2021-07-29 21:13 |
Regulatory News Service
Termination of coverage report
|
Hebrew (modern) | 174.5 KB | ||
| 2021-07-29 21:13 |
Notice of Dividend Amount
Termination of coverage report
|
Russian | 101.2 KB | ||
| 2021-06-13 10:10 |
Regulatory News Service
update Analysis (FROST) following financial report, target price remains at NIS…
|
English | 1.1 MB | ||
| 2021-06-13 10:10 |
Investor Presentation
update Analysis (FROST) following financial report, target price remains at NIS…
|
Russian | 101.2 KB | ||
| 2021-04-11 22:23 |
Earnings Release
update Analysis (FROST) following financial report 2020,target price remains at…
|
English | 1.1 MB | ||
| 2021-04-11 22:23 |
Pre-Annual General Meeting Information
update Analysis (FROST) following financial report 2020,target price remains at…
|
Russian | 98.1 KB | ||
| 2020-12-16 19:22 |
Investor Presentation
Analysis update following financial report:price target is unchanged NIS 2.62
|
English | 1.1 MB | ||
| 2020-12-16 19:22 |
Investor Presentation
Analysis update following financial report:price target is unchanged NIS 2.62
|
Russian | 94.7 KB | ||
| 2020-09-01 21:58 |
Regulatory News Service
Analysis update following financial report:price target is unchanged NIS 2.62
|
English | 1.1 MB | ||
| 2020-09-01 21:58 |
Environmental & Social Information
Analysis update following financial report:price target is unchanged NIS 2.62
|
Russian | 94.7 KB | ||
| 2020-08-24 21:06 |
Earnings Release
update analsis (FORST),price target is unchanged
|
English | 1.1 MB |
Automate Your Workflow. Get a real-time feed of all DNA Group (T.R.) Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for DNA Group (T.R.) Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DNA Group (T.R.) Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops microbiome-modulating ingredients and supplements to manage chronic lifestyle diseases.
United Kingdom
OPTI
United Kingdom
OPTI
Develops precision blood tests using 3D genomics for cancer diagnosis and therapy guidance.
United Kingdom
OBD
United Kingdom
OBD
De-risks oncology drug development for pharma/biotech using modeling and simulation.
United Kingdom
PYC
United Kingdom
PYC
Clinical-stage biopharma developing a first-in-class oral drug for diabetes and obesity.
Sweden
PILA
Sweden
PILA
AI-led biopharma developing drugs for high-need diseases like CRS and metabolic disorders.
United Kingdom
POLB
United Kingdom
POLB
CRO providing proteomics services & TMT® tags to biopharma for drug discovery & biomarkers.
United Kingdom
PRM
United Kingdom
PRM
Develops & licenses Fruitflow®, a patented ingredient for heart health in food & supplements.
United Kingdom
PXS
United Kingdom
PXS
United Kingdom
QUBE
R&D firm using AI and quantum computing to create efficient technologies for Bitcoin mining.
United Kingdom
QBT
United Kingdom
QBT